Basic Information
ID: ALA1116449
Type: Functional
Description: Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of virus-induced cytopathic effect after 5 days by XTT assay
Format: BAO_0000218
Organism: Human immunodeficiency virus 1
Strain: 3B
Cell type: MT2
Target: Human immunodeficiency virus 1(ALA378)
Document: ALA1157759
Antiviral activity against HIV1 3B infected in human MT2 cells assessed as inhibition of virus-induced cytopathic effect after 5 days by XTT assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA1116449
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 287.22 | -0.05 | -0.05 |
| 331.20 | 0.27 | 0.27 |
| 579.43 | 3.29 | 3.29 |
| 737.77 | 5.37 | 5.37 |
| 709.72 | 4.59 | 4.59 |
| 681.66 | 3.81 | 3.81 |
| 613.63 | 3.71 | 3.71 |
| 613.63 | 3.42 | 3.42 |
| 585.57 | 2.92 | 2.92 |
| 585.57 | 2.93 | 2.93 |
| 585.57 | 2.64 | 2.64 |
| 557.52 | 2.15 | 2.15 |
| 529.47 | 1.37 | 1.37 |
| 557.52 | 1.86 | 1.86 |
| 529.47 | 1.37 | 1.37 |
| 520.46 | 3.29 | 3.29 |
| 626.65 | 5.62 | 5.62 |
| 626.65 | 5.62 | 5.62 |
| 622.59 | 4.91 | 4.91 |
| 610.58 | 4.76 | 4.76 |
| 608.57 | 4.66 | 4.66 |
| 596.56 | 4.52 | 4.52 |
| 596.56 | 4.52 | 4.52 |
| 608.57 | 4.52 | 4.52 |
| 612.56 | 3.93 | 3.93 |
| 616.51 | 4.26 | 4.26 |
| 548.51 | 4.07 | 4.07 |
| 548.51 | 3.93 | 3.93 |
| 548.51 | 4.07 | 4.07 |
| 548.51 | 4.07 | 4.07 |
| 546.50 | 3.83 | 3.83 |
| 534.49 | 3.68 | 3.68 |
| 546.50 | 3.68 | 3.68 |
| 534.49 | 3.54 | 3.54 |
| 532.47 | 3.44 | 3.44 |
| 520.46 | 3.29 | 3.29 |
| 532.47 | 3.29 | 3.29 |
| 506.43 | 2.90 | 2.90 |
| 512.36 | 2.40 | 2.40 |
| 507.42 | 3.33 | 3.33 |
| 520.46 | 3.15 | 3.15 |
| 605.39 | 3.44 | 3.44 |
| 542.89 | 2.90 | 2.90 |
| 579.35 | 2.90 | 2.90 |